The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Physician-reported barriers and strategies to using tumor mutational burden (TMB) testing in oncology care: An interview based study.
 
Gieira S Jones
Employment - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Elizabeth A. Szamreta
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Liam Lee
Employment - Merck (I)
Stock and Other Ownership Interests - Merck
 
Radhika Iyer
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Bianca Jackson
Employment - OPEN Health
Consulting or Advisory Role - Merck (Inst)
 
Ning Ning
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Bayer (Inst); BeiGene (Inst); Bristol Myers Squibb (Inst); Daiichi Sankyo (Inst); G1 Therapeutics (Inst); Merck (Inst); Otsuka (Inst); Takeda (Inst)
 
Jennifer Stephens
Employment - Open Health
Leadership - Open Health
Stock and Other Ownership Interests - Open Health
Research Funding - Merck (Inst)
 
Arif Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology; Merck
Research Funding - Bayer (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); FORMA Therapeutics (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Nektar (Inst); Orion (Inst); Pfizer (Inst); POINT Biopharma (Inst); Progenics (Inst); Roche/Genentech (Inst); Sotio (Inst); Taiho Pharmaceutical (Inst)